Trial Details

COMPLETED
Basic Information
Clinical ID c1602
Identifier NCT03071081
Trial Title Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjects
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: TOP1288|DRUG: Placebo to TOP1288
Participant Information
Sponsor Topivert Pharma Ltd
City London
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement MALE
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2017-02-08
Primary Completion Date 2017-06-02
Completion Date 2017-06-02